LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 138

Search options

  1. Article: What today's department says about the future.

    McClennan, B L

    AJR. American journal of roentgenology

    2000  Volume 174, Issue 4, Page(s) 923–924

    MeSH term(s) Forecasting ; Radiology/trends ; United States
    Language English
    Publishing date 2000-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 82076-3
    ISSN 1546-3141 ; 0361-803X ; 0092-5381
    ISSN (online) 1546-3141
    ISSN 0361-803X ; 0092-5381
    DOI 10.2214/ajr.174.4.1740923
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A General Decomposition Pathway for Phosphine-Stabilized Metathesis Catalysts: Lewis Donors Accelerate Methylidene Abstraction

    McClennan, William L / Fogg Deryn E / Lummiss Justin A. M / Rufh Stephanie A

    Journal of the American Chemical Society. 2016 Nov. 09, v. 138, no. 44

    2016  

    Abstract: ... PCy₃)(CHPh) (Ru-2: NHC = H₂IMes, a; IMes, b; H₂IPr, c; IPr, d; H₂ITol, e) and indenylidene ...

    Abstract Sterically accessible Lewis donors are shown to accelerate decomposition during catalysis, for a broad range of Grubbs-class metathesis catalysts. These include benzylidene derivatives RuCl₂(NHC)(PCy₃)(CHPh) (Ru-2: NHC = H₂IMes, a; IMes, b; H₂IPr, c; IPr, d; H₂ITol, e) and indenylidene complexes RuCl₂(NHC)(PCy₃)(C₁₅H₁₀) (NHC = H₂IMes, Ru-2f; IMes, Ru-2g). All of these precatalysts form methylidene complex RuCl₂(NHC)(CH₂) Ru-3 as the active species in metathesis of terminal olefins, and generate RuCl₂(NHC)(PCy₃)(CH₂) Ru-4 as the catalyst resting state. On treatment with a 10-fold excess of pyridine, Ru-4a and Ru-4b decomposed within minutes in solution at RT, eliminating [MePCy₃]Cl A by net loss of three ligands (PCy₃, methylidene, and one chloride), and a mesityl proton. In comparison, loss of A from Ru-4a in the absence of a donor requires up to 3 days at 55 °C. The σ-alkyl intermediate RuCl₂(¹³CH₂PCy₃)(NHC) (py)₂ resulting from nucleophilic attack of free PCy₃ on the methylidene ligand was undetectable for the H₂IMes system, but was spectroscopically observable for the IMes system. The relevance of this pathway to decomposition of catalysts Ru-2a–g was demonstrated by assessing the impact of pyridine on the in situ-generated methylidene species. Slow initiation (as observed for the indenylidene catalysts) did not protect against methylidene abstraction. Importantly, studies with Ru-4a and Ru-4b indicated that weaker donors (THF, MeCN, DMSO, MeOH, and even H₂O) likewise promote this pathway, at rates that increase with donor concentration, and severely degrade catalyst productivity in RCM, even for a readily cyclized substrate. In all cases, A was the sole or major ³¹P-containing decomposition product. For DMSO, a first-order dependence of decomposition rates on DMSO concentration was established. This behavior sends a warning about the use of phosphine-stabilized metathesis catalysts in donor solvents, or with substrates bearing readily accessible donor sites. Addition of pyridine to RuCl₂(H₂IMes)(PCy₃)(CHMe) did not result in ethylidene abstraction, indicating that this decomposition pathway can be inhibited by use of substrates in which the olefin bears a β-methyl group.
    Keywords acetonitrile ; catalysts ; catalytic activity ; chlorides ; dimethyl sulfoxide ; ligands ; methanol ; olefin ; pyridines ; solvents
    Language English
    Dates of publication 2016-1109
    Size p. 14668-14677.
    Publishing place American Chemical Society
    Document type Article
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021%2Fjacs.6b08372
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article: Adverse reactions to iodinated contrast media. Recognition and response.

    McClennan, B L

    Investigative radiology

    1994  Volume 29 Suppl 1, Page(s) S46–50

    MeSH term(s) Anaphylaxis/etiology ; Anaphylaxis/therapy ; Contrast Media/adverse effects ; Humans ; Iodine/adverse effects
    Chemical Substances Contrast Media ; Iodine (9679TC07X4)
    Language English
    Publishing date 1994-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80345-5
    ISSN 1536-0210 ; 0020-9996
    ISSN (online) 1536-0210
    ISSN 0020-9996
    DOI 10.1097/00004424-199405001-00008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: 1993 ACR Intersociety Commission summit meeting: health care system reform--opportunities and exigencies.

    McClennan, B L

    AJR. American journal of roentgenology

    1994  Volume 162, Issue 6, Page(s) 1481–1486

    MeSH term(s) Health Care Reform ; Humans ; Radiology ; Societies, Medical ; United States
    Language English
    Publishing date 1994-06
    Publishing country United States
    Document type Congress
    ZDB-ID 82076-3
    ISSN 1546-3141 ; 0361-803X ; 0092-5381
    ISSN (online) 1546-3141
    ISSN 0361-803X ; 0092-5381
    DOI 10.2214/ajr.162.6.8192040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Radiology summit meeting 1992: the role of radiology in health care reform.

    McClennan, B L

    AJR. American journal of roentgenology

    1993  Volume 160, Issue 3, Page(s) 649–657

    MeSH term(s) Health Policy ; Physician's Role ; Radiology/education ; Referral and Consultation
    Language English
    Publishing date 1993-03
    Publishing country United States
    Document type Congress
    ZDB-ID 82076-3
    ISSN 1546-3141 ; 0361-803X ; 0092-5381
    ISSN (online) 1546-3141
    ISSN 0361-803X ; 0092-5381
    DOI 10.2214/ajr.160.3.8430573
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Contrast media alert.

    McClennan, B L

    Radiology

    1993  Volume 189, Issue 1, Page(s) 35

    MeSH term(s) Contraindications ; Contrast Media/administration & dosage ; Contrast Media/adverse effects ; Drug Labeling ; Humans ; Injections, Spinal ; Iodine/adverse effects ; Myelography ; United States ; United States Food and Drug Administration
    Chemical Substances Contrast Media ; Iodine (9679TC07X4)
    Language English
    Publishing date 1993-10
    Publishing country United States
    Document type Editorial
    ZDB-ID 80324-8
    ISSN 1527-1315 ; 0033-8419
    ISSN (online) 1527-1315
    ISSN 0033-8419
    DOI 10.1148/radiology.189.1.8372215
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Radiology summit meeting--1991: Solutions through synectics.

    McClennan, B L

    AJR. American journal of roentgenology

    1992  Volume 158, Issue 3, Page(s) 675–678

    MeSH term(s) Credentialing ; Radiology ; Research ; Societies, Medical ; United States
    Language English
    Publishing date 1992-03
    Publishing country United States
    Document type Congress
    ZDB-ID 82076-3
    ISSN 1546-3141 ; 0361-803X ; 0092-5381
    ISSN (online) 1546-3141
    ISSN 0361-803X ; 0092-5381
    DOI 10.2214/ajr.158.3.1739020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Radiology Summit Meeting--1990: action strategies for the new decade.

    McClennan, B L

    AJR. American journal of roentgenology

    1991  Volume 156, Issue 4, Page(s) 841–844

    MeSH term(s) Humans ; Radiology ; Societies, Medical ; United States
    Language English
    Publishing date 1991-04
    Publishing country United States
    Document type Congress
    ZDB-ID 82076-3
    ISSN 1546-3141 ; 0361-803X ; 0092-5381
    ISSN (online) 1546-3141
    ISSN 0361-803X ; 0092-5381
    DOI 10.2214/ajr.156.4.2003452
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Oncologic imaging. Staging and follow-up of renal and adrenal carcinoma.

    McClennan, B L

    Cancer

    1991  Volume 67, Issue 4 Suppl, Page(s) 1199–1208

    Abstract: Computed tomography (CT) has emerged from the 1980s to play a dominant role in the pretreatment staging of renal and adrenal carcinomas. For detection, definition (staging), and determination of resectability or recurrence, CT with intravenous contrast ... ...

    Abstract Computed tomography (CT) has emerged from the 1980s to play a dominant role in the pretreatment staging of renal and adrenal carcinomas. For detection, definition (staging), and determination of resectability or recurrence, CT with intravenous contrast enhancement, and more recently, magnetic resonance imaging (MRI) with gadolinium-DTPA, may be the only cross-sectional imaging studies required before institution of appropriate therapy. Carcinoma of the kidney is frequently diagnosed by serendipity or detected on incidental ultrasound or CT examinations. Real-time ultrasound and color flow Doppler offer unique information on tumor vascularity and major venous vascular involvement. Positive predictive values of 96% can be achieved for the diagnosis of renal cell carcinoma using contrast-enhanced CT scanning. For follow-up CT and MRI are the best imaging techniques for evaluation of the retroperitoneum. MRI may distinguish tumor recurrence from fibrosis in selected cases. Because primary neoplasms of the adrenal gland are rare and often exceed 10 cm at the time of initial diagnosis, the functional nature (endocrine) of adrenal carcinoma may be part of the clinical presentation. Because initial stage is critical to survival and extent of surgical therapy, a knowledge of tumor classification is essential to the optimal diagnostic evaluation. Newer imaging tests, CT and MRI, have superseded conventional urography, ultrasound, and radionuclide studies for the diagnosis and staging of adrenal cancer. Early diagnosis and low stage at presentation are critical to survival in patients with adrenal carcinoma. The current concepts for pretreatment imaging evaluation and the role of CT, MRI, and ultrasound are outlined. An oncologic imaging approach based on tumor staging and classification for patients with real or suspected renal cell carcinoma and adrenal carcinoma is essential to optimal patient care.
    MeSH term(s) Adrenal Gland Neoplasms/diagnosis ; Carcinoma/pathology ; Carcinoma/secondary ; Diagnostic Imaging/methods ; Follow-Up Studies ; Humans ; Kidney Neoplasms/diagnosis ; Neoplasm Staging
    Language English
    Publishing date 1991-02-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/1097-0142(19910215)67:4+<1199::aid-cncr2820671516>3.0.co;2-t
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use.

    McClennan, B L

    AJR. American journal of roentgenology

    1990  Volume 155, Issue 2, Page(s) 225–233

    Abstract: The search for better radiopaque iodinated contrast material for intravascular use is continuing, but the recent development of new lower osmolality contrast media (LOCM), both ionic and nonionic, has dramatically affected the practice of radiology. The ... ...

    Abstract The search for better radiopaque iodinated contrast material for intravascular use is continuing, but the recent development of new lower osmolality contrast media (LOCM), both ionic and nonionic, has dramatically affected the practice of radiology. The major issue retarding the introduction of LOCM into clinical practice in this country has been the increased cost of the media. Numerous preliminary assumptions and probabilities about the tolerance, efficacy, and overall safety of LOCM have been documented in scientific studies. The lower osmolality, reduced chemotoxicity, and high hydrophilicity of new compounds, particularly the nonionic variety compared with conventional high osmolality ionic agents (HOCM), offer a significant margin of safety to patients with known risk factors. Mounting data suggest that low or no risk patients are benefited as well, perhaps to an even greater degree. Costly trade-offs to the universal use of LOCM exist, therefore careful consideration of the advantages and disadvantages of LOCM for intravascular administration is required. This article, presented as the Preston M. Hickey Memorial Lecture to the Michigan Radiological Society in March of 1990, explores the historical development of iodinated intravascular contrast media, especially LOCM, and cites existing data that form the basis for various strategies for their use, that is, selective, universal, or nonvascular use. Better, safer, and less expensive contrast media are a realistic expectation in this new decade of technological promise. Reducing adverse side effects from the use of any new drug or technology must be our continued, collective goal.
    MeSH term(s) Chemistry ; Contrast Media/adverse effects ; Contrast Media/history ; Contrast Media/toxicity ; Costs and Cost Analysis ; Europe ; History, 20th Century ; Humans ; Osmolar Concentration ; United States
    Chemical Substances Contrast Media
    Language English
    Publishing date 1990-08
    Publishing country United States
    Document type Historical Article ; Journal Article ; Review
    ZDB-ID 82076-3
    ISSN 1546-3141 ; 0361-803X ; 0092-5381
    ISSN (online) 1546-3141
    ISSN 0361-803X ; 0092-5381
    DOI 10.2214/ajr.155.2.2115244
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top